These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 26069212)

  • 1. Association between renin-angiotensin system antagonist use and mortality in heart failure with severe renal insufficiency: a prospective propensity score-matched cohort study.
    Edner M; Benson L; Dahlström U; Lund LH
    Eur Heart J; 2015 Sep; 36(34):2318-26. PubMed ID: 26069212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction.
    Lund LH; Benson L; Dahlström U; Edner M
    JAMA; 2012 Nov; 308(20):2108-17. PubMed ID: 23188027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between renin-angiotensin system inhibitor use and mortality/morbidity in elderly patients with heart failure with reduced ejection fraction: a prospective propensity score-matched cohort study.
    Savarese G; Dahlström U; Vasko P; Pitt B; Lund LH
    Eur Heart J; 2018 Dec; 39(48):4257-4265. PubMed ID: 30351407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Renin-Angiotensin Inhibitor Treatment With Mortality and Heart Failure Readmission in Patients With Transcatheter Aortic Valve Replacement.
    Inohara T; Manandhar P; Kosinski AS; Matsouaka RA; Kohsaka S; Mentz RJ; Thourani VH; Carroll JD; Kirtane AJ; Bavaria JE; Cohen DJ; Kiefer TL; Gaca JG; Kapadia SR; Peterson ED; Vemulapalli S
    JAMA; 2018 Dec; 320(21):2231-2241. PubMed ID: 30512100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin-angiotensin system blockade in heart failure patients on long-term haemodialysis in Taiwan.
    Tang CH; Chen TH; Wang CC; Hong CY; Huang KC; Sue YM
    Eur J Heart Fail; 2013 Oct; 15(10):1194-202. PubMed ID: 23671265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of renin-angiotensin system inhibitors with long-term outcomes in patients with systolic heart failure and moderate-to-severe kidney function impairment.
    Higuchi S; Kohsaka S; Shiraishi Y; Katsuki T; Nagatomo Y; Mizuno A; Sujino Y; Kohno T; Goda A; Yoshikawa T;
    Eur J Intern Med; 2019 Apr; 62():58-66. PubMed ID: 30737061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between baseline and early worsening of renal function and efficacy of renin-angiotensin-aldosterone system blockade in patients with heart failure: insights from the Val-HeFT study.
    Lesogor A; Cohn JN; Latini R; Tognoni G; Krum H; Massie B; Zalewski A; Kandra A; Hua TA; Gimpelewicz C
    Eur J Heart Fail; 2013 Nov; 15(11):1236-44. PubMed ID: 23787721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between use of statins and outcomes in heart failure with reduced ejection fraction: prospective propensity score matched cohort study of 21 864 patients in the Swedish Heart Failure Registry.
    Alehagen U; Benson L; Edner M; Dahlström U; Lund LH
    Circ Heart Fail; 2015 Mar; 8(2):252-60. PubMed ID: 25575580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal insufficiency as an independent predictor of mortality among women with heart failure.
    Bibbins-Domingo K; Lin F; Vittinghoff E; Barrett-Connor E; Grady D; Shlipak MG
    J Am Coll Cardiol; 2004 Oct; 44(8):1593-600. PubMed ID: 15489091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative associations between angiotensin converting enzyme inhibitors, angiotensin receptor blockers and their combination, and outcomes in patients with heart failure and reduced ejection fraction.
    Savarese G; Edner M; Dahlström U; Perrone-Filardi P; Hage C; Cosentino F; Lund LH
    Int J Cardiol; 2015 Nov; 199():415-23. PubMed ID: 26247798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of renin-angiotensin system inhibitors for patients with heart failure with preserved ejection fraction and mild to moderate chronic kidney disease.
    Tsujimoto T; Kajio H
    Eur J Prev Cardiol; 2018 Aug; 25(12):1268-1277. PubMed ID: 29808753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Renin-Angiotensin System Blockade on Renal Outcomes and Mortality in Pre-Dialysis Patients with Advanced Chronic Kidney Disease.
    Oh YJ; Kim SM; Shin BC; Kim HL; Chung JH; Kim AJ; Ro H; Chang JH; Lee HH; Chung W; Lee C; Jung JY
    PLoS One; 2017; 12(1):e0170874. PubMed ID: 28122064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of angiotensin receptor blocker at discharge in patients with heart failure with reduced ejection fraction: Korean Acute Heart Failure (KorAHF) registry.
    Choi KH; Lee GY; Choi JO; Jeon ES; Lee HY; Cho HJ; Lee SE; Kim MS; Kim JJ; Hwang KK; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Park HY; Cho MC; Oh BH
    Int J Cardiol; 2018 Apr; 257():168-176. PubMed ID: 29506690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of renin-angiotensin system blockade in patients with severe renal insufficiency and heart failure.
    Jang SY; Chae SC; Bae MH; Lee JH; Yang DH; Park HS; Cho Y; Cho HJ; Lee HY; Oh BH; Choi JO; Jeon ES; Kim MS; Lee SE; Kim JJ; Hwang KK; Cho MC; Baek SH; Kang SM; Choi DJ; Yoo BS; Ahn Y; Kim KH; Park HY
    Int J Cardiol; 2018 Sep; 266():180-186. PubMed ID: 29887444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin-angiotensin system blockade reduces cardiovascular events in nonheart failure, stable patients with prior coronary intervention.
    Choi Y; Lim S; Lee KY; Park HW; Byeon J; Hwang BH; Kim JJ; Oh YS; Youn HJ; Jung WS; Seung KB; Chang K
    Coron Artery Dis; 2018 Sep; 29(6):451-458. PubMed ID: 29489465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of spironolactone use with all-cause mortality in heart failure: a propensity scored cohort study.
    Lund LH; Svennblad B; Melhus H; Hallberg P; Dahlström U; Edner M
    Circ Heart Fail; 2013 Mar; 6(2):174-83. PubMed ID: 23386667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia.
    Hsu TW; Liu JS; Hung SC; Kuo KL; Chang YK; Chen YC; Hsu CC; Tarng DC
    JAMA Intern Med; 2014 Mar; 174(3):347-54. PubMed ID: 24343093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between use of β-blockers and outcomes in patients with heart failure and preserved ejection fraction.
    Lund LH; Benson L; Dahlström U; Edner M; Friberg L
    JAMA; 2014 Nov; 312(19):2008-18. PubMed ID: 25399276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin receptor blocker in patients with ST segment elevation myocardial infarction with preserved left ventricular systolic function: prospective cohort study.
    Yang JH; Hahn JY; Song YB; Choi SH; Choi JH; Lee SH; Jeong MH; Choi DJ; Park JS; Park HS; Gwon HC
    BMJ; 2014 Nov; 349():g6650. PubMed ID: 25398372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.